uso de inhibidores de la bomba de

167 Geba GP, Weaver AL, Polis AB, Dixon ME, Schnitzer TJ. Efficacy of Rofecoxib, Celecoxib, andAcetaminophen in Osteoarthritis of the Knee. JAMA. 2002;287:64-71.168 Rampal P, Moore N, VanGanse E, La Parc JM, Wall R, Schneid H et al. Gastrointestinal tolerability ofibuprofen compared with paracetamol and aspirin at over-the-counter doses. J Int Med Res. 2002; 30:301-8.169 Silverfield JC, Kamin M, Wu SC, Rosenthal N; CAPSS-105 Study Group. Tramadol/acetaminophencombination tablets for the treatment of osteoarthritis flare pain: a multicenter, outpatient, randomized,double-blind, placebo-controlled, parallel-group, add-on study. Clin Ther. 2002;24:282-97.170 Graham DY, Smith JL. Effects of aspirin and an aspirin-acetaminophen combination on the gastricmucosa in normal subjects. A double-blind endoscopic study. Gastroenterology. 1985;88:1922-5. 65171 Stern AI, Hogan DL, Kahn LH, Isenberg JI. Protective effect of acetaminophen against Aspirin- andEthanol-Induced damage to the human gastric mucosa. Gastroenterology. 1984;86:728-33.172 Lanas A, Martin-Mola E, Ponce J, Navarro F, Pique JM, Blanco FJ. Recomendaciones de laAsociación Española de Gastroenterología y de la Sociedad Española de Reumatología. Disponible en:http://www.ser.es/ArchivosDESCARGABLES/consensos/ConsensoAEG-SER-Final090603.pdf.(consultado 5-3-2011).173Rahme E, Pettitt D, LeLorier J. Determinants and sequelae associated with utilization ofacetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population. Arthritis& Rheum. 2002;46:3046-54.174 Garcia Rodriguez LA, Hernandez-Diaz S. Relative risk of upper gastrointestinal complications amongusers of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology. 2001;12: 570-6.175 Bianchi Porro G, Ardizzone S, Petrillo M, Caruso I, Montrone F. Endoscopic assessment of the effectsof dipyrone (metamizol) in comparison to paracetamol and placebo on the gastric and duodenal mucosaof healthy adult volunteers. Digestion. 1996;57:186-90.176 Laporte JR, Carné X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation toprevious use of analgesic and non-steroidal anti-inflammatory drugs. Lancet. 1991; 1:85-9.177 Lanas A, Serrano P, Bajador E, Fuentes J, Sáinz R. Risk of upper gastrointestinal bleeding associatedwith non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs. Eur JGastroenterol Hepatol. 2003;15:1-6.178 Edwards JE, Meseguer F, Faura CC, Moore RA, McQuay HJ. Single-dose dipyrone for acutepostoperative pain. Cochrane Database Syst Rev. 2001; (3):CD003227.179 Roderick PJ, Wickes HC, Meade TW. The gastrointestinal toxicity of aspirin: an overview ofrandomised controlled trials. Br J Clin Pharmacol. 1993; 35: 219-26.180 Algra A, Greving JP. Aspirin in primary prevention: sex and baseline risk matter. Lancet. 2009; 373(30): 1821-22.181 Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelettherapy: II. Maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ. 1994; 308:159-68.182 SIGN. Scottish Intercollegiate Guidelines Network. [Internet] Escocia. Antithrombotic TherapySection 11: Antiplatelet agents. Disponible en:http://www.sign.ac.uk/guidelines/fulltext/36/section11.html (consultada 7-3-2011).105